Women are at increased risk of developing AKI during cardiac surgery – a major unmet clinical need. CardioRenal Systems provides the only clinically validated solution

CardioRenal Systems®

CardioRenal Systems® is the developer of the only clinically validated solution for preventing Acute Kidney Injury (AKI) in common hospitalizations from cardiac surgery and interventional cardiology to ICU. RenalGuard Therapy® is CE approved with growing sales throughout EMEA and was granted breakthrough designation by the FDA.